Italy· 046271021

SILODOSINA DOC

A silodosin product containing silodosina, registered in Italy by DOC GENERICI S.R.L., on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC G04CA04

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedSILODOSINA DOCATCG04CA04REGISTER NO.046271021PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Silodosin is registered in 17 of 19 countries.

Countries holding a registration under ATC G04CA04 (silodosin), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 10 of them publish a price we can compare per daily dose

Silodosin · ATC G04CA04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of silodosin costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.28 in Italy to $1.39 in Switzerland — a ×5.0 gap.

  • Italy: $0.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Silodosin · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.39
  • IT Italy$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Silodosina
Manufacturer
DOC GENERICI S.R.L.
Country
Italy (IT)
ATC code
G04CA04
ATC class
Silodosin
Defined daily dose
8 mg, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    046271021
    "8 MG CAPSULE RIGIDE" 30 CAPSULE IN BLISTER AL-PVC/PE/PVDC
    EUR 7.32

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

148 interactions on record for silodosin.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Silodosin · interactions on record

148 records

  • 9 severe
  • 139 moderate

Most severe, free to view

  • KetoconazoleH02CA03severe
  • ClarithromycinJ01FA09severe
  • KetoconazoleJ02AB02severe
  • Darunavir and cobicistatJ05AR14severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Silodosin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silodosin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Belgium · Silodosin Ab
  • Bulgaria · Пирсео, Сидарсо
  • Germany · Silbesan, Silodosin Al
  • Spain · Silodosina Abamed, Silodosina Alter
  • France · Silodosine Arrow, Silodosine Biogaran
  • Croatia · Niksol, Sidarso
  • Hungary · Pirseo, Sidarso
  • Iceland · Silodosin Recordati, Silodyx
  • Liechtenstein · Silodosin Recordati, Silodyx
  • Lithuania · Sidarso
  • Netherlands · Silodosin Aurobindo, Silodosine Amarox
  • Norway · Silodosin Recordati, Silodyx
  • Poland · Sidarso, Silodosin Aurovitas
  • Portugal · Silodosin Ipca, Silodosin Msn
  • Romania · Sidarso
  • Slovenia · Sidarso
  • Slovakia · Sidarso, Silodosin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d59f78a9-44e5-4458-804e-7a517e3c58a4
GET /v1/drugs/d59f78a9-44e5-4458-804e-7a517e3c58a4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"8 MG CAPSULE RIGIDE\" 30 CAPSULE IN BLISTER AL-PVC/PE/PVDC",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Silodosina",
  "reference_pack": "30 UNITA' 8 MG - USO ORALE",
  "public_price_eur": 7.32,
  "ssn_reference_price_eur": 7.32
}

See everything about silodosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.